...
首页> 外文期刊>BMC Ophthalmology >Two-year topographic and densitometric outcomes of accelerated (45?mW/cm2) transepithelial corneal cross-linking for keratoconus: a case-control study
【24h】

Two-year topographic and densitometric outcomes of accelerated (45?mW/cm2) transepithelial corneal cross-linking for keratoconus: a case-control study

机译:加速的两年地形和致密度结果(45?MW / cm2)KeratoConus的TransepeLelial角膜交联:一个案例对照研究

获取原文

摘要

Conventional corneal cross-linking is effective for retarding the progression of keratoconus. However the long-term efficacy and safety of accelerated (45?mW/cm2) transepithelial corneal cross-linking (ATE-CXL) on progressive keratoconus (KC) treatment is not fully understood. The purpose of this study is to evaluate the 2-year changes in corneal topographic parameters and densitometry values after ATE-CXL for KC. Twenty-five progressive eyes of 25 KC patients (KC group) and 25 eyes of 25 myopes without KC (control group) were enrolled. Corneal topography and densitometry values were evaluated pre-operatively and at 6, 12 and 24?months post-operatively in the KC group. The mean values of flat keratometry (K1), steep keratometry (K2), mean keratometry (Km), corneal astigmatism (CA), maximum keratometry (Kmax), central corneal thickness (CCT), thinnest corneal thickness (TCT), anterior corneal elevation (ACE) and posterior corneal elevation (PCE) all remained unchanged over time (all P values ?0.05). The densitometry values of the anterior, central, posterior and total layers over the annular diameters 0?mm to 2?mm (Φ0-2?mm) and Φ2-6?mm all decreased significantly (all P values ?0.05). Subgroups with Km?≥?50.30D or ACE ≥35.3?μm progressed significantly when compared with those with Km??50.30D (F?=?8.167, P?=?0.004) or ACE?35.3?μm (F?=?5.207, P?=?0.022). K1, K2, Km, CA, Kmax, CCT, TCT, ACE, and PCE values may remain stable but severer KC patients tend to have poorer long-term outcomes. The densitometry values of the full corneal thickness (total layer over Φ0-2?mm and Φ2-6?mm) may decrease to normal levels at 2?years after ATE-CXL for KC.
机译:常规的角膜交联对于延缓角蛋白酶的进展是有效的。然而,促进的长期疗效和安全性(45μm/ cm2)TransepeLelial角膜交联(ATE-CXL)上的进步角蛋白酶(KC)治疗不完全理解。本研究的目的是评估ATE-CXL kc后角膜地形参数和密度测定值的2年变化。招募了25 kc患者(KC组)和25只近视的25千克患者的二十五次渐进眼睛,没有KC(对照组)。角膜地形和密度测定值在KC组后连续和6,12和24个月进行评估。平静计(K1),陡峭的音轨(K2),平均角膜斑(km),角膜散术(Km),最大角膜厚度(CCT),最薄的角膜厚度(TCT),前角膜,扁平角膜厚度(TCT),前角膜,扁平角膜升高(ACE)和后部角膜仰角(PCE)随着时间的推移保持不变(所有P值>?0.05)。在环形直径0Ω直径上的前,中心,后和总层的密度测定值0≤mm至2Ωmm(φ0-2≤mm)和φ2-6Ωmm,所有均显着下降(所有P值?0.05)。与km?≥50.30d或ace≥35.3?与km的亚组或≥35.3?μm在与kmα相比下显着进展?<?50.30d(f?= 10.167,p?= 0.004)或ace <35.3?μm(f? =?5.207,p?= 0.022)。 K1,K2,KM,CA,KMAX,CCT,TCT,ACE和PCE值可能保持稳定,但严重的KC患者往往具有较差的长期结果。全角膜厚度的密度测定值(φ0-2≤mm和φ2-6Ωmm和φ2-6≤mm)的致密量值可能降至kc kc酸℃下的2年后的正常水平。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号